Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.28 USD | -5.21% | -1.09% | -39.38% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company is in a robust financial situation considering its net cash and margin position.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.82 for the current period. Therefore, the company is undervalued.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-39.38% | 602M | C- | ||
+18.63% | 85.14B | C+ | ||
-27.41% | 72.06B | B- | ||
+2.75% | 27.07B | C+ | ||
-9.66% | 17.43B | B | ||
-1.96% | 16.98B | A- | ||
+3.96% | 16.02B | A- | ||
+7.75% | 13.87B | B- | ||
+72.83% | 13.06B | C- | ||
+72.50% | 12.79B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ACCD Stock
- Ratings Accolade, Inc.